DE60320661D1 - System mit kontrollierter freisetzung bioaktiver wirkstoffe - Google Patents

System mit kontrollierter freisetzung bioaktiver wirkstoffe

Info

Publication number
DE60320661D1
DE60320661D1 DE60320661T DE60320661T DE60320661D1 DE 60320661 D1 DE60320661 D1 DE 60320661D1 DE 60320661 T DE60320661 T DE 60320661T DE 60320661 T DE60320661 T DE 60320661T DE 60320661 D1 DE60320661 D1 DE 60320661D1
Authority
DE
Germany
Prior art keywords
controlled release
active substances
biologically active
cellulose polymer
hydrophilic cellulose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60320661T
Other languages
English (en)
Other versions
DE60320661T2 (de
Inventor
Jean Paul Remon
Els Mehuys
Chris Vervaet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universiteit Gent
Original Assignee
Universiteit Gent
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universiteit Gent filed Critical Universiteit Gent
Application granted granted Critical
Publication of DE60320661D1 publication Critical patent/DE60320661D1/de
Publication of DE60320661T2 publication Critical patent/DE60320661T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DE60320661T 2002-09-30 2003-09-24 System mit kontrollierter freisetzung bioaktiver wirkstoffe Expired - Lifetime DE60320661T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0222612.4A GB0222612D0 (en) 2002-09-30 2002-09-30 Controlled delivery system for bioactive substances
GB0222612 2002-09-30
PCT/EP2003/010715 WO2004028503A1 (en) 2002-09-30 2003-09-24 Controlled delivery system for bioactive substances

Publications (2)

Publication Number Publication Date
DE60320661D1 true DE60320661D1 (de) 2008-06-12
DE60320661T2 DE60320661T2 (de) 2009-05-28

Family

ID=9944998

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60320661T Expired - Lifetime DE60320661T2 (de) 2002-09-30 2003-09-24 System mit kontrollierter freisetzung bioaktiver wirkstoffe

Country Status (9)

Country Link
US (1) US20060003006A1 (de)
EP (1) EP1545455B1 (de)
AT (1) ATE393622T1 (de)
AU (1) AU2003277907A1 (de)
CA (1) CA2500061A1 (de)
DE (1) DE60320661T2 (de)
ES (1) ES2305524T3 (de)
GB (1) GB0222612D0 (de)
WO (1) WO2004028503A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8895064B2 (en) 1999-06-14 2014-11-25 Cosmo Technologies Limited Controlled release and taste masking oral pharmaceutical composition
DE60005819T2 (de) 1999-06-14 2004-05-06 Cosmo S.P.A. Geschmacksmaskierte orale pharmazeutische zusammensetzungen mit kontrollierter abgabe
US20050025825A1 (en) 2003-07-31 2005-02-03 Xanodyne Pharmacal, Inc. Tranexamic acid formulations with reduced adverse effects
US8022106B2 (en) 2004-03-04 2011-09-20 Ferring B.V. Tranexamic acid formulations
US20090215898A1 (en) * 2004-03-04 2009-08-27 Xanodyne Pharmaceuticals, Inc. Tranexamic acid formulations
US7947739B2 (en) 2004-03-04 2011-05-24 Ferring B.V. Tranexamic acid formulations
US20050244495A1 (en) 2004-03-04 2005-11-03 Xanodyne Pharmaceuticals, Inc. Tranexamic acid formulations
US20100210732A1 (en) * 2005-11-02 2010-08-19 Najib Babul Methods of Preventing the Serotonin Syndrome and Compositions for Use Therefor
US9125833B2 (en) * 2005-11-02 2015-09-08 Relmada Therapeutics, Inc. Multimodal abuse resistant and extended release opioid formulations
US20090082466A1 (en) * 2006-01-27 2009-03-26 Najib Babul Abuse Resistant and Extended Release Formulations and Method of Use Thereof
US8329744B2 (en) * 2005-11-02 2012-12-11 Relmada Therapeutics, Inc. Methods of preventing the serotonin syndrome and compositions for use thereof
CA2671197A1 (en) * 2006-07-21 2008-01-24 Lab International Srl Hydrophobic abuse deterrent delivery system
US20080187579A1 (en) * 2007-02-01 2008-08-07 Pavan Bhat Extended-release dosage form
KR101104901B1 (ko) 2008-05-23 2012-01-12 김영곤 능동 약물 방출형 서모 로드의 제조방법 및 이에 의해제조된 서모 로드
TWI394594B (zh) * 2009-03-06 2013-05-01 China Chemical & Pharmaceutical Co Ltd 錠劑藥學組成物及其製造方法
US20100280117A1 (en) * 2009-04-30 2010-11-04 Xanodyne Pharmaceuticals, Inc. Menorrhagia Instrument and Method for the Treatment of Menstrual Bleeding Disorders
US8486435B2 (en) * 2010-06-30 2013-07-16 Evonik Corporation Core-sheath implant device having an inner core lobe
JP2014525423A (ja) 2011-08-30 2014-09-29 ウニベルシテイト ヘント 多層放出配合物
US10154964B2 (en) 2011-09-07 2018-12-18 Cosmo Technologies Limited Controlled release and taste masking oral pharmaceutical composition
WO2015071812A1 (en) * 2013-11-18 2015-05-21 Wockhardt Limited Solid oral modified-release composition comprising budesonide or salt thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0406315B1 (de) * 1988-03-24 1992-11-11 Bukh Meditec A/S Geregelte verabreichungszusammensetzung
DK469989D0 (da) * 1989-09-22 1989-09-22 Bukh Meditec Farmaceutisk praeparat
MX9300110A (es) * 1992-01-13 1994-07-29 Gerhard Gergely Preparacion farmaceutica en la forma de una tableta de efervescencia o de desintegracion o de un granulado de tipo instanteneo y procedimiento para su preparacion.
US5503843A (en) * 1994-04-22 1996-04-02 Flora Inc. Transdermal delivery of alpha adrenoceptor blocking agents
DE19539361A1 (de) * 1995-10-23 1997-04-24 Basf Ag Verfahren zur Herstellung von mehrschichtigen, festen Arzneiformen zur oralen oder rektalen Verabreichung
JP3565548B2 (ja) * 1997-08-29 2004-09-15 株式会社資生堂 まつ毛用化粧料
EP1067910B1 (de) * 1998-04-03 2004-05-26 Egalet A/S Zusammensetzung mit kontrollierter wirkstoff-freisetzung
DE1003485T1 (de) * 1998-06-11 2000-11-02 Em Ind Inc Mikroosmotisches gesteuertes arzneistoffabgabesysteme
FR2782006B1 (fr) * 1998-08-07 2002-04-19 Gattefosse Ets Sa Composition a liberation prolongee apte a former une micro-emulsion
SE9902742D0 (sv) * 1999-07-20 1999-07-20 Astra Ab New pharmaceutical formultion

Also Published As

Publication number Publication date
EP1545455B1 (de) 2008-04-30
EP1545455A1 (de) 2005-06-29
CA2500061A1 (en) 2004-04-08
DE60320661T2 (de) 2009-05-28
GB0222612D0 (en) 2002-11-06
ATE393622T1 (de) 2008-05-15
ES2305524T3 (es) 2008-11-01
US20060003006A1 (en) 2006-01-05
AU2003277907A1 (en) 2004-04-19
WO2004028503A1 (en) 2004-04-08

Similar Documents

Publication Publication Date Title
DE60320661D1 (de) System mit kontrollierter freisetzung bioaktiver wirkstoffe
ATE267007T1 (de) Pharmazeutische tablette geeignet zur wirkstofffreisetzung in aufeinanderfolgenden und vorherbestimmbaren zeiträumen
DE60118395D1 (de) Pharmazeutische zusammensetzungen mit verzögerter freisetzung für die parenterale applikation von hydrophilen wirkstoffen
WO2001082895A3 (en) Guaifenesin sustained release formulation and tablets
DE69918310D1 (de) Tablette mit verzögerter freigabe enthaltend einen blutzuckersenkenden wirkstoff und einen antihyperglyzemischen wirkstoff
WO2003103637A3 (en) MODIFIED RELEASE MULTIPLE UNIT DRUG DELIVERY SYSTEMS
DE60038848D1 (de) Feste Arzneizusammensetzungen mit gesteuerter Wirkstoffabgabe hergestellt mittels eines Thermoformverfahrens
DE60132077D1 (de) Vitaminzusammenstellung mit verzögerter freigabe
ATE251449T1 (de) Geschmacksmaskierte orale pharmazeutische zusammensetzungen mit kontrollierter abgabe
AR002009A1 (es) Composicion farmaceutica, procedimiento para la manufactura de un polvo de proliposoma como el utilizado en dicha composicion, procedimiento para lamanufactura de dicha composicion, uso de dicha composicion farmaceutica en la manufactura de un medicamento y dispositivo inhalador de polvo seco.
MXPA04006670A (es) Compuesto superabsorbente y articulos absorbentes que incluyen al mismo.
FI964175A0 (fi) Hidastetusti vapauttavia matriisipellettejä ja menetelmä niiden valmistamiseksi
ES2152992T3 (es) Metodo para obtener un material bioerosionable para la liberacion sostenida de un medicamento, y el material obtenido del metodo.
ATE326264T1 (de) Pharmazeutische formulierungen mit kontrollierter wirkstoff-freigabe enthaltend milchsäure-polymer, sowie deren herstellung
WO2007127795A3 (en) Chitosan/nanocrystalline hydroxyapatite composite microsphere-based scaffolds
SE9704401D0 (sv) Matrix pellets for greasy, oily or sticky drug substances
ATE367803T1 (de) Subcutane implantate mit begrenzter initialer wirkstoff-freisetzung und deren anschliessende lineare veränderliche verlängerte freisetzung
EP1608408A4 (de) Biologisch aktives material, konjugiert mit biokompatiblem polymer mit 1:1 komplex, herstellungsverfahren dafür und dieses enthaltende pharmazeutische zusammensetzung
GEP20094589B (en) Orally dispersible pharmaceutical composition and process for the preparation thereof
WO1999047543A3 (en) Sustained-release composition including amorphous polymer
DE60109279D1 (de) Pharmazeutische zusammensetzungen mit oligosacchariden und deren herstellung
DE50008259D1 (de) Feste pharmazeutische zubereitungen mit nanosols aus chitosan, sowie deren herstellung
SI0804165T1 (en) Solid medicament form with active agent distributed in polymer material

Legal Events

Date Code Title Description
8364 No opposition during term of opposition